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Summary
Background: adhesive capsulitis (AC) results in
progressive painful restriction in range of move-
ment and can reduce function and quality of life.
Whilst it has been associated with diabetes melli-
tus (DM), there is considerable variation in the re-
ported prevalence of AC in the diabetic popula-
tion. The aim of this study is to determine through
meta-analysis the prevalence of AC in DM and ex-
amine whether it is influenced by type of DM or in-
sulin therapy. We also aim to further establish the
prevalence of DM in patients presenting with AC. 
Methods: we conducted a literature search for
terms regarding AC and DM on Embase and
Pubmed NCBI. 
Results: of 5411 articles identified, 18 were se-
lected. Meta-analysis showed that patients with
DM were 5 (95% CI 3.2-7.7) times more likely than
controls to have AC. The overall prevalence of AC
in DM was estimated at 13.4% (95% CI 10.2-
17.2%). Comparison of prevalence in patients on
insulin vs other treatments showed no significant
difference between the two. Meta-analysis esti-
mated the prevalence of DM in AC at 30% (95% CI
24-37%). 
Conclusion: to our knowledge this is the first
meta-analysis to estimate the overall prevalence
of diabetes in a population with AC. A high preva-
lence of AC exists in DM and equally a high
prevalence of DM is present in AC. Screening for
DM should be considered in patients presenting
with AC. 
KEY WORDS: idiopathic adhesive capsulitis, frozen
shoulder, diabetes, prevalence.
Level of Evidence: Level III (meta-analysis).
Introduction
Adhesive capsulitis (AC) is a self-limiting condition.
Patients typically present with an atraumatic history
of progressive painful restriction in range of move-
ment of the gleno-humeral joint. They exhibit a cap-
sular pattern of restriction with external rotation being
the most restricted followed by abduction in the plane
of the scapula and then flexion. Codman in 1934 de-
scribed a diagnostic criterion comprising of idiopathic
onset, painful restriction of all gleno-humeral move-
ments with limitation of flexion and external rotation
with a normal radiograph1,2.
AC is more common in women with a peak age of on-
set of 56 years3,4. It can have a variable duration but
usually lasting between 1-3 years3-5 without interven-
tion, and can impact on patients’ activities of daily liv-
ing and reduce quality of life. Resolution may range
from complete to varying degrees of limitation in
shoulder movement. 
Management of AC may be operative or non-operative,
though the best management option remains controver-
sial6. In a survey of upper limb orthopaedic surgeons in
the United Kingdom, those preferring non-operative
management favoured physiotherapy, whereas those
preferring operative intervention favoured arthroscopic
arthrolysis. Preference of management was largely
based on surgeon experience and training as opposed
to strong scientific evidence7.
Although the aetiology of AC remains unknown, sever-
al risk factors are associated with this condition. These
include previous trauma, increasing age, female gen-
der, dyslipidaemia, hypertension, thyroid dysfunction
and diabetes mellitus (DM)8-15. Sung et al. in 201416
found a statistically significant association of idiopath-
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ic AC with hypercholesterolaemia and inflammatory
lipoproteinaemias, though it was not possible to es-
tablish a cause-effect relationship. 
The prevalence of AC in the general population is
classically quoted as 2%, though it has been suggest-
ed that the real figure is closer to 0.75%17. However
AC has a more variable prevalence in the diabetic
population, in the reported literature. 
Understanding prevalence rates of AC in DM, and
DM in AC is important in guiding physicians and sur-
geons managing these conditions. It may guide re-
search studies evaluating interventions in AC as to
the inclusion of diabetic patients so as to reduce the
risk of bias. Furthermore understanding the relation-
ship between AC and DM may provide insights into
the pathogenesis of AC. 
In this study we review the available published litera-
ture, to estimate the prevalence of AC in DM and de-
termine whether rates are influenced by DM type and
treatment. We also aim to identify the prevalence of
DM in AC. 
Methodology
We conducted a literature search on 12th February
2014 using Embase and Pubmed NCBI (National
Centre of Biotechnology Information). The search
terms used were ‘frozen shoulder,’ ‘adhesive capsuli-
tis AND shoulder’. In the search, there were no re-
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Table 1. Summary of studies identifying AC in populations with DM.
Study Population N Prevalence 
Kidwai et al. 201320 India 413                    
210 T2DM       
203 Controls 
11% (in DM) 
p=0.001 (T2DM vs Controls) 
Attar 201221 Jeddah, Saudi Arabia 252  6.70% 
Mathew et al. 
201122 
India 310  16.45% 
Ray et al. 201123 Calcutta, India 100  18% 
Dehghan et al. 
201024 
Yazd, Iran 510                  
150 DM 
13.30% (in DM)  
Gupta et al. 200825 Udupi, India 233 29.61% 
Aydeniz et al. 
200826 
Turkey 203                        
102 T2DM                  
101 non-DM 
14.7 (in DM) 
p=0.009 (T2DM vs non-DM) 
Thomas et al. 
200727 
Scotland 1067                
865 DM          
202 non-DM 
4.4% 
p=0.005 
Sarkar et al. 200328 Kolkata, India 1660                 
860 DM             
800 non-DM 
17.9 (in DM) 
p<0.001 (DM vs non-DM) 
Cagliero et al. 
200229 
Massachusetts 300 12%  
(DM vs non-DM) 
Arkkila et al. 199630 Finland 425 14% Overall 
10% T1DM 
22% T2DM 
Pal et al. 198631 Newcastle, UK 184                      
109 DM                
75 non-DM 
19% (in DM) 
Bridgman 197232 London, UK 1400                
800 DM          
600 non-DM 
10.8% (in DM) 
p<0.005 (DM vs non-DM) 
 
 
 
 
 
Study Population N Prevalence (Event Rate) 
Wang et al. 201333 Australia 263                  
87 with AC 
20% (in AC)  
p=0.005 (AC vs non-AC) 
Tighe and Oakley 200834 USA 88 38.6% 
Milgrom et al. 200814 Israel 224 29% 
Rauoof et al. 20045 Kashmir, India 100 27% 
Withrington et al. 198535 London, UK 60 40% 
 
Table 2. Summary of studies identifying DM in populations with AC.
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strictions on date of publication or language. Ethical
approval was not required as there was no handling
of confidential data. The study was conducted and
meets the ethical standards as per the recommenda-
tions set out by Padulo et al. (2013)18.
The search returned 5411 articles. The titles and ab-
stracts of these were reviewed to identify those for
full review. Studies were included if they identified
prevalence of AC in a diabetic population or DM in a
population with AC. Studies were excluded if the di-
agnosis of AC was not idiopathic i.e. it was related to
trauma or post-operative. Case reports, duplicated
data, incidence studies, reviews and opinion articles
were also excluded. The studies had to define their
understanding of AC.
Statistical analysis
A random-effects model was used to perform meta-
analysis. Confidence intervals (95%) and summary
risk ratios were calculated. Heterogeneity was as-
sessed using tau2, I2, Q and p values. The level of
significance was fixed at p<0.05. The data was
analysed using Comprehensive meta-analysis ver-
sion 2 (Biostat; Englewood, New Jersey, USA).
Results
Our initial search identified 5411 articles of which 18
were included for analysis (Fig. 1). Table 1 identifies
the prevalence of AC in diabetes and Table 2 demon-
strates the prevalence of DM in AC.
Meta-analysis
Thirteen studies examined the prevalence of AC in
DM and meta-analysis showed an overall prevalence
of AC in diabetes of 13.4% (95% CI 10.2-17.2%,
Q=130.4, df12, p<0.001, I2=90.8, tau2=0.27) (Fig. 2).
Funnel plot analysis did not show an obvious small
study effect (Fig. 3). 
Three studies compared AC prevalence in patients
with T1DM and T2DM. Meta-analysis of AC preva-
lence showed no significant difference between
T1DM and T2DM (5.8%, 95% CI 1.2-24.5 vs 12.4
95% CI 3-38.9, Q=0.5, p=0.47) (Fig. 4).
Two older studies compared AC prevalence in popu-
lations designated as having IDDM and NIDDM.
Meta-analysis of AC prevalence showed no signifi-
cant difference between IDDM and NIDDM (18.2%,
95% CI 10.6-29.3 vs. 11.8, 95% CI 6.9-19.6, Q=1.3,
p=0.26) (Fig. 5). Similarly, meta-analysis of AC
prevalence in patients on insulin treatment compared
to NIDDM showed no significant difference (13.5%,
95% CI 8.3-21.3 vs. 12.3, 95% CI 5.9-23.6, Q=0.05,
p=0.8) (Fig. 6). 
Five studies compared AC prevalence in patients with
DM compared to controls. The study by Sarkar et al.
(2003)28 used patients attending a rheumatology clin-
ic as controls and as many rheumatological condi-
tions can produce shoulder pathology that may be
mistaken for AC, we excluded this study from the
analysis. Meta-analysis showed that patients with DM
were five times more likely than controls (95% CI 3.2-
7.7, p<0.001) to have AC (Fig. 7). 
Five studies assessed the prevalence of DM in a pop-
ulation with AC and meta-analysis showed that the
prevalence of diabetes in this population was 30%
(95% CI 24-37%, Q=10.4, df4, p=0.034, I2=61.6,
tau2=0.08) (Fig. 8). Funnel plot analysis did not show
an obvious small study effect (Fig. 9). 
Discussion
Our meta-analysis demonstrates an overall mean
prevalence of AC in DM of 13.4%. Conversely, the
mean prevalence of DM in a population with AC was
30%. To our knowledge this is the first meta-analysis
to estimate the overall prevalence of DM in a popula-
tion with AC. In addition, we show that diabetic pa-
tients are 5 times more likely to develop AC com-
pared to non-diabetic controls. Our analysis found no
significant difference in the prevalence of AC be-
tween patients with T1DM and T2DM and also be-
tween patients on insulin therapy compared to oral
hypoglycaemic agents. Yian et al. (2012)36 have pre-
viously shown no relationship between the preva-
lence of AC and glycaemic control.
AC is considered more severe and resistant to treat-
ment in the diabetic population3,28,37. In a recent
study evaluating the outcomes of arthroscopic re-
lease in patients with AC, whilst 90% had excellent or
good outcomes, the 10% who had fair outcomes, all
had T1DM38. Indeed, in a separate study, DM was
associated with a worse modified Constant score and
range of shoulder movements post arthroscopic re-
lease for AC39. However, DM was not shown to be
associated with a worse outcome following arthro-
graphic distension for AC40.
The underlying reasons in patients with DM for poten-
tially worse outcomes and prolonged course in AC
are complex. Boivin et al.41 looked at the properties
of the Achilles tendon of diabetic mice. They identi-
fied a significant increase in tendon diameter, and
significant decreases in stiffness and elastic modulus
in tendons from diabetic mice compared to controls,
suggesting that altered tissue properties may account
for the observed resistance of diabetics to treatment.
In addition, a consequence of visceral adiposity in
DM is inflammation that occurs via several inflamma-
tory mediators42,43. Adipocytes secrete proteins and
cytokines such as tumour necrosis factor alpha (TNF-
α) and interleukin-6 (IL-6) resulting in overproduction
of other pro-inflammatory cytokines, which in turn ex-
acerbate inflammation. Adipocytes also release ex-
cess IL-13, which has been shown to result in hepatic
fibrosis in mouse models44 and may thus contribute
to synovial and connective tissue fibrosis. Chronic in-
flammation can lead to excessive accumulation of
Muscles, Ligaments and Tendons Journal 2016;6 (1):26-3428
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Figure 1. Literature search results (PRISMA flowchart 2009)19.
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4UVEZOBNF4VCHSPVQXJUIJOTUVEZ4UBUJTUJDTGPSFBDITUVEZ Event rate and 95% CI
Event Lower Upper
rate limit limit Z-Value
Kidwai unspecified 0.110 0.074 0.160 -9.480
Attar unspecified 0.067 0.042 0.105 -10.453
Mathew unspecified 0.165 0.127 0.210 -10.608
Ray unspecified 0.180 0.116 0.268 -5.826
Dehghan unspecified 0.133 0.087 0.197 -7.797
Gupta unspecified 0.296 0.241 0.358 -6.034
Aydeniz unspecified 0.147 0.091 0.230 -6.288
Thomas Combined 0.044 0.031 0.060 -17.586
Sarkar Combined 0.175 0.151 0.201 -17.293
Cagliero unspecified 0.120 0.088 0.162 -11.214
Arkkila Combined 0.141 0.111 0.178 -12.962
Pal Combined 0.192 0.129 0.277 -5.903
Bridgman Combined 0.107 0.088 0.131 -18.548
0.134 0.102 0.172 -12.188
0.00-0.50 -0.25 0.25 0.50
M  
Figure 2. Meta-analysis of prevalence of AC in populations with DM. The ‘subgroup within study’ defines whether the study
population was combined (T1DM and T2DM) or unspecified.
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Group by
Subgroup within study
Study name Subgroup within study Statistics for each study Event rate and 95% CI
Event Lower Upper 
rate limit limit Z-Value
Type1 Thomas Type1 0.177 0.122 0.249 -6.965
Type1 Sarkar Type1 0.001 0.000 0.017 -4.707
Type1 Arkkila Type1 0.103 0.073 0.144 -11.222
Type1 0.058 0.012 0.245 -3.289
Type2 Thomas Type2 0.014 0.007 0.027 -12.616
Type2 Sarkar Type2 0.379 0.332 0.428 -4.761
Type2 Arkkila Type2 0.224 0.161 0.302 -5.997
Type2 0.124 0.030 0.389 -2.544
-0.50 -0.25 0.00 0.25 0.50
Figure 4. Meta-analysis of prevalence of AC in patients with T1DM and T2DM.

Group by
Subgroup within study
Study name Subgroup within study Statistics for each study Event rate and 95% CI
Event Lower Upper 
rate limit limit Z-Value
IDDM Pal IDDM 0.204 0.113 0.339 -3.840
IDDM Bridgman IDDM 0.168 0.121 0.229 -8.114
IDDM 0.182 0.106 0.293 -4.708
NIDDM Pal NIDDM 0.183 0.104 0.301 -4.481
NIDDM Bridgman NIDDM 0.089 0.069 0.114 -16.438
NIDDM 0.118 0.069 0.196 -6.583
-0.50 -0.25 0.00 0.25 0.50
Figure 5. Meta-analysis of prevalence of AC in populations with IDDM and NIDDM.

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Figure 3. Funnel plot of prevalence of AC in populations with DM.
MLTJ 1-2016 4b_.  06/05/16  15:31  Pagina 30
Muscles, Ligaments and Tendons Journal 2016;6 (1):26-34 31
Frozen shoulder and diabetes: a meta-analysis of prevalence

Group by
Subgroup within study
Study name Subgroup within study Statistics for each study Event rate and 95% CI
Event Lower Upper 
rate limit limit Z-Value
Insulin Thomas Insulin 0.177 0.122 0.249 -6.965
Insulin Sarkar Insulin 0.001 0.000 0.017 -4.707
Insulin Arkkila Insulin 0.103 0.073 0.144 -11.222
Insulin Pal Insulin 0.204 0.113 0.339 -3.840
Insulin Bridgman Insulin 0.168 0.121 0.229 -8.114
Insulin 0.135 0.083 0.213 -6.592
NIDDM Pal NIDDM 0.183 0.104 0.301 -4.481
NIDDM Bridgman NIDDM 0.089 0.069 0.114 -16.438
NIDDM 0.123 0.059 0.236 -4.856
-0.50 -0.25 0.00 0.25 0.50
Figure 6. Meta-analysis of prevalence of AC in patients with DM on insulin therapy versus oral hypoglycaemic agents.

Study name Statistics for each study Risk ratio and 95% CI
Risk Lower Upper 
ratio limit limit Z-Value p-Value
Thomas 8.828 1.216 64.100 2.153 0.031
Pal 3.612 1.292 10.099 2.449 0.014
Bridgman 4.607 2.645 8.024 5.396 0.000
Dehghan 8.667 2.624 28.622 3.543 0.000
4.958 3.191 7.704 7.121 0.000
0.01 0.1 1 10 100
Figure 7. Meta-analysis of prevalence of AC in patients with DM versus non-diabetic controls.

Study name Statistics for each study Event rate and 95% CI
Event Lower Upper 
rate limit limit Z-Value
Wang 0.200 0.129 0.297 -5.172
Tighe 0.386 0.290 0.491 -2.120
Milgrom 0.290 0.234 0.353 -6.081
Rauoofe 0.270 0.192 0.365 -4.416
Withrington 0.400 0.285 0.528 -1.539
0.304 0.243 0.373 -5.242
-0.50 -0.25 0.00 0.25 0.50
Figure 8. Meta-analysis of prevalence of DM in populations presenting with AC.
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collagen and other extracellular matrix components,
which may result in destruction of normal tissue ar-
chitecture45. Production of free fatty acids (FFAs)
from adipocytes also leads to up-regulation of pro-in-
flammatory mediators and thus overproduction of in-
flammatory cytokines43,46,47. FFAs may also promote
neutrophil survival and cause defective efferocyto-
sis43. Neutrophils secrete TNF-α and IL-6, which may
result in insulin resistance. Resultant hyperglycaemia
interferes with the inflammatory cascade and inhibits
phagocytosis of bacteria and apoptotic cells43,48. The
combination of these factors could result in persis-
tence of inflammation and limited disease resolution.
AC is considered to be an inflammatory and fibrotic
condition49. In the early stages of AC synovial and
capsular fibrosis may occur as a result of inflamma-
tion and hypervascular synovial proliferation,49,50 in
part driven by increased expression of synovial vas-
cular endothelial growth factor2,6. Up-regulation of in-
flammatory mediators in the capsule have also been
demonstrated44,49,51,52. A study by Cho et al.50
demonstrated that acid sensing ion channels may
play a role in the pathogenesis of AC by mediating in-
flammatory pain.
Snedeker and Gautieri52 reviewed collagen crosslinks
in DM. They suggested that an increase in connective
tissue stiffness in DM maybe linked to non-enzymatic
oxidative reactions between glucose and collagen re-
sulting in the formation of advanced glycation end-
products53-55. Furthermore, in a recent review of hor-
mones and tendinopathies, Oliva et al.55 concurred
that advanced glycation end-products result in
changes in the microstructural organization of colla-
gen fibres56,57. Alterations in the ultrastructure of col-
lagen may thus result in changes in the biomechani-
cal properties of tendons. 
Our findings have important implications for clinical
practice. They confirm the high prevalence and in-
creased relative risk of AC in DM. This should increase
the awareness of primary care providers and diabetolo-
gists to consider AC in patients presenting with shoul-
der symptoms. Earlier diagnosis with prompt referral
and treatment may prevent progression to chronic,
treatment resistant AC. In addition, rheumatologists
and orthopaedic surgeons assessing patients with AC
should enquire about a history of DM and if such a his-
tory is absent they should consider undertaking an as-
sessment of HbA1c. The latter test is a simple blood
test, which can enable patients to be stratified into
those with normal glucose tolerance (HbA1c <5.7%),
pre-diabetes (5.7-6.4%) and T2DM (HbA1c ≥ 6.5%)58. 
Limitations
We acknowledge a limitation of our analysis was that
only four studies compared patients with DM to con-
trol subjects and the majority of the studies did not
assess the type of DM. Furthermore, several earlier
studies made reference to IDDM and NIDDM, terms
that are now obsolete. Despite this, our meta-analysis
has allowed us to estimate the overall prevalence of
AC in DM and DM in AC from the currently available
literature. It also provides an impetus to undertake
more detailed and larger analyses if we are to better
manage this debilitating condition.
Conclusion 
In conclusion, diabetologists, rheumatologists and or-
thopaedic surgeons should be aware of the high
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Figure 9. Funnel plot of prevalence of DM in populations presenting with AC.
MLTJ 1-2016 5b_.  10/05/16  15:34  Pagina 32
prevalence of DM in patients with AC and vice versa.
Future studies assessing outcomes of interventions
for AC should consider stratifying subjects into those
with normal glucose tolerance, impaired glucose tol-
erance and T2DM based on HbA1c. This would pro-
vide meaningful insights into the effects of dysgly-
caemia and overall glycaemic control in relation to
the development and outcomes of AC.
List of abbreviations:
CI – confidence interval
df – degrees of freedom
DM – diabetes mellitus
FFA – free fatty acid
HbA1c – haemoglobin A1c
IAC – idiopathic adhesive capsulitis
IDDM – insulin dependent diabetes mellitus
IL – interleukin
N (or n) – number 
NCBI – National Centre of Biotechnology Information
NIDDM – non-insulin dependent diabetes mellitus
SD – standard deviation
TNF – tumour necrosis factor
T1DM – type 1 diabetes mellitus
T2DM – type 2 diabetes mellitus
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